RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

    MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J.

    Ann Intern Med. 2008 Feb 5;148(3):197-213. Epub 2007 Dec 17.PMID: 18087050 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

    Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J.

    Health Technol Assess. 2005 Jun;9(22):1-160. Review.PMID: 15929857 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effectiveness and safety of vitamin D in relation to bone health.

    Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

    Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

    Iwamoto J, Takeda T, Sato Y.

    Curr Med Res Opin. 2006 May;22(5):919-28. Review.PMID: 16709313 [PubMed - indexed for MEDLINE]Related articles

    5.

    Osteoporosis: trials and tribulations.

    Seeman E.

    Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.PMID: 9302899 [PubMed - indexed for MEDLINE]Related articles

    6.

    Medical treatment of vertebral osteoporosis.

    Lippuner K.

    Eur Spine J. 2003 Oct;12 Suppl 2:S132-41. Epub 2003 Sep 17. Review.PMID: 13680313 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fracture prevention in postmenopausal osteoporosis: a review of treatment options.

    McCarus DC.

    Obstet Gynecol Surv. 2006 Jan;61(1):39-50. Review.PMID: 16359568 [PubMed - indexed for MEDLINE]Related articles

    8.

    Strontium ranelate for preventing and treating postmenopausal osteoporosis.

    O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

    Cochrane Database Syst Rev. 2006 Jul 19;3:CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326. PMID: 16856092 [PubMed - indexed for MEDLINE]Related articles

    9.

    Potential of alfacalcidol for reducing increased risk of falls and fractures.

    Ringe JD, Schacht E.

    Rheumatol Int. 2009 Aug;29(10):1177-85. Epub 2009 Jan 22.PMID: 19159932 [PubMed - indexed for MEDLINE]Related articles

    10.

    Management of osteoporosis due to ovarian failure.

    Eastell R.

    Med Pediatr Oncol. 2003 Sep;41(3):222-7. Review.PMID: 12868123 [PubMed - indexed for MEDLINE]Related articles

    11.

    WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

    Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

    Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523. PMID: 17636764 [PubMed - indexed for MEDLINE]Related articles

    12.

    Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.

    Mullins CD, Ohsfeldt RL.

    J Manag Care Pharm. 2003 Mar-Apr;9(2):150-8.PMID: 14613344 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Treatment of postmenopausal osteoporosis.

    Delmas PD.

    Lancet. 2002 Jun 8;359(9322):2018-26. Review.PMID: 12076571 [PubMed - indexed for MEDLINE]Related articles

    14.

    Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.

    Cranney A, Adachi JD.

    Drug Saf. 2005;28(8):721-30. Review.PMID: 16048357 [PubMed - indexed for MEDLINE]Related articles

    15.

    Update of current therapeutic options for the treatment of postmenopausal osteoporosis.

    Epstein S.

    Clin Ther. 2006 Feb;28(2):151-73. Review.PMID: 16678639 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risedronate for the prevention and treatment of postmenopausal osteoporosis.

    Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

    Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523. PMID: 14584020 [PubMed - indexed for MEDLINE]Related articles

    17.

    Osteoporosis management.

    Rozenberg S, Vandromme J, Ayata NB, Filippidis M, Kroll M.

    Int J Fertil Womens Med. 1999 Sep-Oct;44(5):241-9. Review.PMID: 10569453 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevention of osteoporosis and fractures.

    Ullom-Minnich P.

    Am Fam Physician. 1999 Jul;60(1):194-202. Review.PMID: 10414638 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.

    Recker RR, Kendler D, Recknor CP, Rooney TW, Lewiecki EM, Utian WH, Cauley JA, Lorraine J, Qu Y, Kulkarni PM, Gaich CL, Wong M, Plouffe L Jr, Stock JL.

    Bone. 2007 Apr;40(4):843-51. Epub 2006 Dec 19.PMID: 17182297 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.

    Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.

    Calcif Tissue Int. 2005 Mar;76(3):176-86. Epub 2005 Feb 7.PMID: 15692726 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity